Literature DB >> 23144292

Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland.

Yujie Wang1, Jaakko Tuomilehto, Pekka Jousilahti, Veikko Salomaa, Bin Li, Riitta Antikainen, Markku Mähönen, Peter T Katzmarzyk, Gang Hu.   

Abstract

OBJECTIVES: To evaluate the association of serum γ-glutamyltransferase (GGT) levels with heart failure (HF) risk in the Finnish population.
DESIGN: Prospective population-based cohort study.
SETTING: The present study, which is a part of FINRISK study, was carried out in Finland. Subject study cohorts included 18 353 Finnish men and 19 726 women who were 25-74 years of age and free of HF at baseline. Main outcome measures HF (636 men and 445 women) during a mean follow-up of 14.5 years.
RESULTS: Baseline measurement of different levels of serum GGT was used to predict incident HF. The multivariable-adjusted (age, sex, study area, study year, smoking, education, alcohol consumption, physical activity, valvular heart disease, body mass index (BMI), systolic blood pressure, total cholesterol at baseline, myocardial infarction and diabetes at baseline and during follow-up) HRs of HF at five GGT groups (using the 25th, 50th, 75th and 90th percentiles) were 1.00, 1.16 (95% CI: 0.97 to 1.38), 1.20 (1.00 to 1.45), 1.29 (1.04 to 1.60) and 1.82 (1.45 to 2.29) (P(trend)<0.001). Stratification by smoking status, alcohol consumption and BMI gave similar results, while stronger association was observed among subjects aged <60 years (P(trend)=0.001) compared with subjects 60+ years of age (P(trend)=0.173).
CONCLUSIONS: Moderate to high levels of serum GGT (from the 50th to the 90th percentiles) were significantly associated with incident HF in men and women in Finland, and the predictive power was stronger in subjects aged <60 years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23144292     DOI: 10.1136/heartjnl-2012-302972

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  13 in total

1.  Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control.

Authors:  Sophie Cassidy; Kate Hallsworth; Christian Thoma; Guy A MacGowan; Kieren G Hollingsworth; Christopher P Day; Roy Taylor; Djordje G Jakovljevic; Michael I Trenell
Journal:  Cardiovasc Diabetol       Date:  2015-02-13       Impact factor: 9.951

Review 2.  Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Mantovani; Stefano Ballestri; Amedeo Lonardo; Giovanni Targher
Journal:  Dig Dis Sci       Date:  2016-01-25       Impact factor: 3.199

3.  Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Authors:  Lisa B VanWagner; Mary E Rinella
Journal:  Curr Hepatol Rep       Date:  2016-03-28

4.  Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy.

Authors:  Hideaki Jinnouchi; Kazunori Morita; Takahiro Tanaka; Ayami Kajiwara; Yuki Kawata; Kentaro Oniki; Junji Saruwatari; Kazuko Nakagawa; Koji Otake; Yasuhiro Ogata; Akira Yoshida; Seiji Hokimoto; Hisao Ogawa
Journal:  Cardiovasc Diabetol       Date:  2015-05-08       Impact factor: 9.951

5.  γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.

Authors:  Setor K Kunutsor; Hassan Khan; Jari A Laukkanen
Journal:  J Am Heart Assoc       Date:  2016-02-08       Impact factor: 5.501

6.  Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.

Authors:  Lisa B VanWagner; Jane E Wilcox; Laura A Colangelo; Donald M Lloyd-Jones; J Jeffrey Carr; Joao A Lima; Cora E Lewis; Mary E Rinella; Sanjiv J Shah
Journal:  Hepatology       Date:  2015-06-26       Impact factor: 17.298

7.  Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers.

Authors:  Yuka Noborisaka; Masao Ishizaki; Michiko Yamazaki; Ryumon Honda; Yuichi Yamada
Journal:  Nephrourol Mon       Date:  2013-11-13

8.  Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure.

Authors:  Filippo Valbusa; Stefano Bonapace; Cristina Grillo; Luca Scala; Andrea Chiampan; Andrea Rossi; Giacomo Zoppini; Amedeo Lonardo; Guido Arcaro; Christopher D Byrne; Giovanni Targher
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis.

Authors:  Claudia Torino; Francesco Mattace-Raso; Jan L C M van Saase; Maurizio Postorino; Giovanni Luigi Tripepi; Francesca Mallamaci; Carmine Zoccali
Journal:  Oxid Med Cell Longev       Date:  2016-07-25       Impact factor: 6.543

10.  Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.

Authors:  Filippo Valbusa; Stefano Bonapace; Davide Agnoletti; Luca Scala; Cristina Grillo; Pietro Arduini; Emanuela Turcato; Alessandro Mantovani; Giacomo Zoppini; Guido Arcaro; Christopher Byrne; Giovanni Targher
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.